The purpose of the project is to prevent the leading cause of postoperative mortality after heart surgery low cardiac output syndrome lcos by providing at home ICU level monitoring to children and…
Active Cooperative Agreement Awarded Last action
- Award ID
- D25AC00206
- Recipient
-
The Cleveland Clinic Foundation UEI TDGUJ1WA4UJ9
- Awarding agency
-
Interior Business Center
Office of Policy Management and Budget, Department of the Interior
- Obligated
- $2,732,120
Award facts
- Assistance listing
- 93.384 ADVANCED RESEARCH PROJECTS AGENCY for HEALTH (ARPA-H)
- Completion date 62% complete
- Place of performance
- Cleveland, OH, USA
Award details come from USAspending.gov.
Description
The purpose of the project is to prevent the leading cause of postoperative mortality after heart surgery low cardiac output syndrome lcos by providing at home ICU level monitoring to children and adults with congenital heart disease (CHD). This will be achieved through the creation of a battery operated flexible ultrathin quad modal wireless device ETATTOO for daily absolute cardiac output (CO) monitoring. The current state of the art monitoring devices rely on downstream metrics (e.g. lactic acidosis) are invasive requiring pulmonary arterial catheterization or are unfit for children. Additional state of the art tools for cardiac output monitoring are costly to operate and are limited by single time point measurements (e.g. magnetic resonance imaging MRI).one in every four patients with congenital heart disease will require surgery at some point. Lcos is the leading cause of postoperative mortality in those patients. The proposed program is considered a critical technology effort because IT aims to noninvasively estimate cardiac output in congenital heart disease patients of all ages and to help prevent lcos. In addition the technology can be used at home and IT can be applied to other heart sensing applications. Current technology and approaches to noninvasive continuous cardiac output monitoring (NICCOM) are not ideal and can present a higher risk profile. Currently ECG patches are used to monitor CHD patients intermittently every year and they do not measure all relevant information. Implantable sensors have revolutionized longer term patient monitoring but they are not well studied and present infection risk. The advantage of collaborating with the government on this endeavor is that if successful IT can provide medical grade clinically backed affordable accessible flexible and disposable wearable technology to americans. A successful project would result in state of the art algorithms for both noninvasive cardiac output monitoring and lcos predictions following surgery. Additionally noninvasive quad modal wearable hardware (ETATTOO) would be produced to measure physiological parameters. There is great commercialization and market potential for the ETATTOO wearable monitoring device (1) the device covers both pediatric and adult markets (2) the AI algorithms can be standalone or licensed to other companies and (3) the ETATTOO device hardware can be used for applications outside of lcos prediction.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Original award | $2,732,120 |
Subawards
| Subrecipient | Amount | Awarded |
|---|---|---|
| Georgia TECH Research Corp | $605,665 | |
| The University Of Texas Southwestern Medical Center | $272,443 | |
| University Of Texas At Austin | $584,444 |
Quick answers
Who received award D25AC00206?
D25AC00206 was awarded to The Cleveland Clinic Foundation by Interior Business Center (Office of Policy Management and Budget) on August 20, 2025.
How much is award D25AC00206 worth?
$2,732,120 has been obligated on D25AC00206.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award